(S)-3-(4-Fluoro-benzenesulfinyl)-pyrrolidine hydrochloride
- $413 - $544
- Product name: (S)-3-(4-Fluoro-benzenesulfinyl)-pyrrolidine hydrochloride
- CAS: 1354025-28-7
- MF: C10H13ClFNOS
- MW: 249.7327232
- EINECS:
- MDL Number:MFCD21098442
- Synonyms:(S)-3-(4-Fluoro-benzenesulfinyl)-pyrrolidine hydrochloride;(3S)-3-((4-Fluorophenyl)sulfinyl)pyrrolidine hydrochloride;(S)-3-((S)-(4-fluorophenyl)sulfinyl)pyrrolidine hydrochloride
4 prices
Selected condition:
Brand
- Apolloscientific
- Chemenu
- Crysdot
- SynQuest Laboratories
Package
- 500mg
- 1g
- ManufacturerApolloscientific
- Product numberPC408298
- Product description(S)-3-(4-Fluoro-benzenesulfinyl)-pyrrolidinehydrochloride
- Packaging500mg
- Price$493
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM197488
- Product description(3S)-3-((4-Fluorophenyl)sulfinyl)pyrrolidinehydrochloride 95%
- Packaging1g
- Price$413
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11282570
- Product description(3S)-3-((4-Fluorophenyl)sulfinyl)pyrrolidinehydrochloride 95+%
- Packaging1g
- Price$442
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number8H65-7-S0
- Product description(S)-3-(4-Fluorobenzenesulfinyl)pyrrolidine hydrochloride
- Packaging500mg
- Price$544
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Apolloscientific | PC408298 | (S)-3-(4-Fluoro-benzenesulfinyl)-pyrrolidinehydrochloride | 500mg | $493 | 2021-12-16 | Buy |
Chemenu | CM197488 | (3S)-3-((4-Fluorophenyl)sulfinyl)pyrrolidinehydrochloride 95% | 1g | $413 | 2021-12-16 | Buy |
Crysdot | CD11282570 | (3S)-3-((4-Fluorophenyl)sulfinyl)pyrrolidinehydrochloride 95+% | 1g | $442 | 2021-12-16 | Buy |
SynQuest Laboratories | 8H65-7-S0 | (S)-3-(4-Fluorobenzenesulfinyl)pyrrolidine hydrochloride | 500mg | $544 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|